Top Section/Ad
Top Section/Ad
Most recent
Calendar quirk could keep issuance going in December
◆ Praemia refis at a tighter coupon ◆ Schneider lands tight at the short end ◆ Minimal concessions needed
French biotech seeks to accelerate cancer vaccine program
More articles/Ad
More articles/Ad
More articles
-
Number of Riyadh listings has swollen as economy grows and liberalises -
Acquisitive company also prints bonds following Valinor purchase
-
Better book than last sell-down with new long-only institutions coming into the stock while others add to positions
-
Boxer Retail set to price IPO at top of range
-
Parent company rescues spin-off in turnaround plan
-
Two largest block trades of the year have been Pfizer sell-downs in Haleon
